- Home
- DHX vs IPHA Comparison
DHX vs IPHA Comparison
Compare DHX & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHX
- IPHA
- Stock Information
- Founded
- DHX 1991
- IPHA 1999
- Country
- DHX United States
- IPHA France
- Employees
- DHX N/A
- IPHA N/A
- Industry
- DHX Business Services
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- DHX Consumer Discretionary
- IPHA Health Care
- Exchange
- DHX Nasdaq
- IPHA Nasdaq
- Market Cap
- DHX 136.8M
- IPHA 160.1M
- IPO Year
- DHX 2007
- IPHA 2019
- Fundamental
- Price
- DHX $1.48
- IPHA $1.98
- Analyst Decision
- DHX Strong Buy
- IPHA Strong Buy
- Analyst Count
- DHX 2
- IPHA 1
- Target Price
- DHX $5.25
- IPHA $11.50
- AVG Volume (30 Days)
- DHX 133.2K
- IPHA 16.2K
- Earning Date
- DHX 05-07-2025
- IPHA 03-27-2025
- Dividend Yield
- DHX N/A
- IPHA N/A
- EPS Growth
- DHX N/A
- IPHA N/A
- EPS
- DHX 0.01
- IPHA N/A
- Revenue
- DHX $141,926,000.00
- IPHA $20,831,349.00
- Revenue This Year
- DHX N/A
- IPHA $220.44
- Revenue Next Year
- DHX $1.64
- IPHA $81.85
- P/E Ratio
- DHX $261.21
- IPHA N/A
- Revenue Growth
- DHX N/A
- IPHA N/A
- 52 Week Low
- DHX $1.32
- IPHA $1.29
- 52 Week High
- DHX $3.32
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- DHX 36.73
- IPHA 48.63
- Support Level
- DHX $1.32
- IPHA $1.77
- Resistance Level
- DHX $1.74
- IPHA $2.03
- Average True Range (ATR)
- DHX 0.18
- IPHA 0.08
- MACD
- DHX 0.00
- IPHA -0.01
- Stochastic Oscillator
- DHX 28.07
- IPHA 65.63
About DHX DHI Group Inc.
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and ClearanceJobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on our websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.